Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis
1998

PAI-2 as a Prognostic Marker in Lung Cancer

Sample size: 105 publication Evidence: high

Author Information

Author(s): H Yoshino, Y Endo, Y Watanabe, T Sasaki

Primary Institution: Kanazawa University, Kanazawa, Japan

Hypothesis

Is decreased expression of plasminogen activator inhibitor 2 (PAI-2) associated with lymph node metastasis in primary lung cancer?

Conclusion

Decreased expression of PAI-2 is significantly correlated with lymph node metastasis and poor prognosis in lung cancer patients.

Supporting Evidence

  • PAI-2 expression was detected in only half of the lung cancer cases studied.
  • Lower PAI-2 levels were significantly associated with lymph node metastasis.
  • Patients with low PAI-2 expression had a worse prognosis compared to those with higher levels.

Takeaway

This study found that lower levels of a protein called PAI-2 in lung cancer tissues can mean the cancer is more likely to spread and that patients may not do as well.

Methodology

The study examined PAI-2 expression in lung cancer tissues using immunohistochemical staining and RT-PCR techniques.

Participant Demographics

{"mean_age":63.8,"sex_distribution":{"male":76,"female":29},"histology":{"squamous_cell_carcinoma":40,"adenocarcinoma":53,"large_cell_carcinoma":6,"small_cell_carcinoma":6}}

Statistical Information

P-Value

p<0.0005

Statistical Significance

p<0.0005

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication